Using Video Images to Improve Advance Care Planning in Patients With Cancer

NCT ID: NCT00970125

Last Updated: 2012-05-01

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 80 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2009-08-31
• Study Completion Date: 2011-06-30

Brief Summary

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone.

Detailed Description

The purpose of this study is to study whether preferences for the goals of care for 80 subjects with end-stage cancer are altered after viewing a video outlining the goals of care compared to their initial preferences after hearing a verbal description of the goals of care alone. Subjects will choose among three goals of care, life prolonging care, basic medical care, and comfort care.

Conditions

Advanced Cancer

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Cancer subjects

Group Type: EXPERIMENTAL

video

Intervention Type: BEHAVIORAL

outline of the goals of care

Interventions

video

outline of the goals of care

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

1. Terminal, progressive cancer with poor prognosis whose treatment intent is palliative, based on the following definition:

• All patients with brain cancer, liver cancer, inoperable non-small cell lung carcinoma, pancreatic cancer, or gallbladder cancer; OR
• Patients with the following cancers: metastatic colon cancer or stage III or IV non-small cell lung cancer; OR
• Patients with the following cancers, if first-line therapy has failed and limited response is expected to second-line therapy: breast cancer, colorectal cancer, head and neck cancer, stomach cancer, esophageal cancer, melanoma, leukemia, ovarian cancer, prostate cancer, renal cancer, sarcoma, lung cancer, myeloma, or lymphoma.
• The terms terminal, progressive, poor prognosis, palliative intent and limited response will be judged by the patient's oncologist (and not by the RSA or consenting professional).

2. Return patient visit (defined as a patient known to the oncologist from previous assessments and treatments, where the working and personal relationship has been established and not a new patient to the clinic).

3. English speaking. Only English-speaking patients will be included in our present study since English is the validated language of our study tools.

4. Given the sensitive nature of the study, clinicians will decide whether the patient is a potentially appropriate subject based on their knowledge of the patient.

5. Able to provide informed consent.

6. Age greater than or equal to 21.

Exclusion Criteria

1. MMSE < 25.

2. Psychological state not appropriate for end-of-life discussion as determined by the treating clinician.

• Minimum Eligible Age: 21 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Massachusetts General Hospital

OTHER

Sponsor Role: lead

Responsible Party

Angelo E. Volandes, MD

Faculty

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Angelo E. Volandes, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Memorial Sloan Kettering

New York, New York, United States

Countries

United States

Other Identifiers

R21CA139121-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2008-P-002156/2

Identifier Type: -

Identifier Source: org_study_id